Dr. Agarwal's Eye Hospital Limited carries a market capitalization of 24.19B, placing it among publicly traded companies globally. Its enterprise value stands at 24.77B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 24.19B |
| Enterprise Value | 24.77B |
Dr. Agarwal's Eye Hospital Limited currently has 4.83M shares outstanding.
| Shares Outstanding | 4.83M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Dr. Agarwal's Eye Hospital Limited trades at a trailing price-to-earnings ratio of 44.32. The price-to-sales ratio is 6.37, and the price-to-book ratio stands at 465.93.
| PE Ratio | 44.32 |
| PS Ratio | 6.37 |
| PB Ratio | 465.93 |
| P/TBV Ratio | 7.06 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Dr. Agarwal's Eye Hospital Limited trades at an EV/EBITDA multiple of 34.94 and an EV/FCF ratio of 406.30. The EV/Sales ratio of 7.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 34.94 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.01 |
| EV / EBITDA | 34.94 |
| EV / EBIT | 34.94 |
| EV / FCF | 406.30 |
Dr. Agarwal's Eye Hospital Limited maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 94.18, indicating elevated leverage, while an interest coverage ratio of 8.70 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.23 |
| Quick Ratio | 0.89 |
| Debt / Equity | 94.18 |
| Debt / EBITDA | 4.60 |
| Interest Coverage | 8.70 |
Dr. Agarwal's Eye Hospital Limited posts a return on equity of 48.80 and a return on invested capital of 8.67.
| Return on Equity (ROE) | 48.80 |
| Return on Assets (ROA) | 7.36 |
| Return on Invested Capital (ROIC) | 8.67 |
| Return on Capital Employed (ROCE) | 13.11 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.57 |
Over the trailing twelve months, Dr. Agarwal's Eye Hospital Limited has paid 171.10M in income taxes, reflecting an effective tax rate of 25.20.
| Income Tax | 171.10M |
| Effective Tax Rate | 25.20 |
Dr. Agarwal's Eye Hospital Limited's stock has gained approximately 12.53401% over the past 52 weeks. The 50-day moving average sits at 5,046.69, while the 200-day moving average is 5,012.68.
| Beta (5Y) | N/A |
| 52-Week Price Change | 12.53401% |
| 50-Day Moving Average | 5,046.69 |
| 200-Day Moving Average | 5,012.68 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Dr. Agarwal's Eye Hospital Limited generated 3.53B in revenue and converted that into 507.80M in net income, yielding earnings per share of 106.04. EBITDA reached 709.00M, while operating income came in at 709.00M.
| Revenue | 3.53B |
| Gross Profit | 2.77B |
| Operating Income | 709.00M |
| Pretax Income | 679.00M |
| Net Income | 507.80M |
| EBITDA | 709.00M |
| EBIT | 709.00M |
| Earnings Per Share (EPS) | 106.04 |
Dr. Agarwal's Eye Hospital Limited holds 996.60M in cash and equivalents against 3.26B in total debt, resulting in a net debt position of 751.80M. Total book value stands at 48.30M, with working capital of 251.60M providing operational flexibility.
| Cash & Cash Equivalents | 996.60M |
| Total Debt | 3.26B |
| Net Debt | 751.80M |
| Equity (Book Value) | 48.30M |
| Book Value Per Share | 10.09 |
| Working Capital | 251.60M |
Dr. Agarwal's Eye Hospital Limited operates with a gross margin of 78.32, reflecting its pricing power and cost economics. The operating margin of 20.08 and net profit margin of 14.38 provide insight into operational efficiency.
| Gross Margin | 78.32 |
| Operating Margin | 20.08 |
| Pretax Margin | 19.23 |
| Profit Margin | 14.38 |
| EBITDA Margin | 20.08 |
Dr. Agarwal's Eye Hospital Limited posts an Altman Z-Score of 4.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.05 |